Holen Sie sich die Stockscreener-App
14.17
4.73%
0.64
Handel nachbörslich:
14.33
0.16
+1.13%
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
RLAY Maintained by Guggenheim -- Price Target Raised to $26 - GuruFocus
RLAY stock declines pre-market after $175M offering — despite fresh bullish calls on Relay's zovegalisib - MSN
Guggenheim raises Relay Therapeutics stock price target on drug profile By Investing.com - Investing.com Australia
RLAY Maintained by HC Wainwright & Co. -- Price Target Raised to $28 - GuruFocus
H.C. Wainwright raises Relay Therapeutics stock price target to $28 on trial data - Investing.com Nigeria
Guggenheim Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $26 - Moomoo
Relay Therapeutics shares jump after positive vascular anomalies trial results (RLAY) - MSN
RLAY stock lights up on vascular anomalies treatment data boost – 60% of patients show sharp reduction in lesion volume - MSN
Relay rises on mid-stage trial data for lead asset in vascular anomalies - MSN
RLAY Stock Declines Pre-Market After $175M Offering — Despite Fresh Bullish Calls On Relay's Zovegalisib - Stocktwits
Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular AnomaliesSlideshow (NASDAQ:RLAY) 2026-05-22 - Seeking Alpha
Is Relay Therapeutics a Buy After Promising Trial Results? - Yahoo Finance
Relay Therapeutics prices $275M public offering of common stock at $12/share - MSN
Is Relay Therapeutics a Buy After Promising Trial Results? - The Motley Fool
New Forecasts: Here's What Analysts Think The Future Holds For Relay Therapeutics, Inc. (NASDAQ:RLAY) - Moomoo
Relay Therapeutics Announces $275 Million Public Offering of Common Stock – Details from SEC Form 8-K Filing - Minichart
Relay Therapeutics (RLAY) Is Up 6.9% After Follow-On Offering And Early Zovegalisib Data Release - Yahoo Finance
Relay Therapeutics Announces Major Underwritten Equity Offering - TipRanks
Relay Therapeutics Stock Rises on Promising Clinical Data and Analyst Upgrades - IndexBox
Relay Therapeutics Launches $12-Per-Share Equity Offering Under Jefferies, TD; Nets About $297 Million - TradingView
Relay Therapeutics (NASDAQ: RLAY) prices $296.8 million public stock offering - Stock Titan
Relay Therapeutics (RLAY) files $12 per-share offering for 22.9M shares - Stock Titan
RLAY Stock Surges As Zovegalisib Data Ignite Bullish Targets - StocksToTrade
Relay Therapeutics (RLAY) Launches $275M Public Offering at $12 Per Share - GuruFocus
Relay Therapeutics Prices $275 Million Public Offering - Moomoo
Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade) (RLAY) - Seeking Alpha
RLAY Technical Analysis | Trend, Signals & Chart Patterns | RELAY THERAPEUTICS INC (NASDAQ:RLAY) - ChartMill
Relay Therapeutics prices $275M stock offering at $12/share By Investing.com - Investing.com Nigeria
Relay Therapeutics Announces Pricing of Public Offering of Common Stock - Investing News Network
Relay Therapeutics: Gross Expected to Be Approximately $275M >RLAY - Moomoo
RLAY Secures Larger Offering with Updated Terms - GuruFocus
Relay Therapeutics prices $275M stock offering at $12/share - Investing.com
Relay Therapeutics Prices Public Offering at $12 per Share - Intellectia AI
Relay Therapeutics announces pricing of public offering of common stock - marketscreener.com
Relay Therapeutics: Underwritten Public Offering of 22.9M Shares Priced at $12.00 Each >RLAY - Moomoo
Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock - TradingView
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):